An Open-Label Study Evaluating the Long-Term Efficacy, Quality of Life, and Safety of Lidose-Isotretinoin (ABSORICA) Capsules Administered Without Food in Patients with Severe Recalcitrant Nodular Acne: Interim Analysis of 20-Week Active Treatment Period

Authors

Andrea Zaenglein
James Del Rosso

Publication/Presentation Date

2-2018

Volume

2

Issue

1

Published In/Presented At

DOI: https://doi.org/10.25251/skin.2.supp.32

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine Faculty

Document Type

Article